AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05497037 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PRF stimulation
Description: One time 500 kHZ stimulation for 15 min
Study NCT05137444 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LYB001
Description: The investigational vaccine, with its antigen consisting of receptor-binding domain (RBD) from SARS-CoV-2 and virus-like particle (VLP) vector, adjuvanted with aluminum hydroxide.
Study NCT05137444 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Aluminum hydroxide
Study NCT05357703 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard treatment + Active B-Cure laser
Description: The B-Cure laser pro is a portal, non-invasive, photobiomodulation device, that emits light in the near infrared (808nm) over an area of 1X4.5 cm2 with power output of 250mW, and energy dose of 5J/minute.
Study NCT05319821 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Receive ECHO training
Description: Active Intervention
Study NCT05319821 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Offered ECHO training in year 5
Description: Delayed Intervention
Study NCT05347576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-393(2)
Description: QD, PO
Study NCT05347576 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-501, D759, D150, D029
Description: QD, PO
Study NCT05591508 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: Ketogenic diet will be in the form of artificial powder which can be diluted and given through NG tube. It will be started at a ratio of 1:1 followed by daily increment (2:1,3:1 and 4:1) till a urine ketone of 2+ is seen
Study NCT05891834 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INV-202
Description: tablet, once daily, oral
Study NCT05891834 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: tablet, once daily, oral
Study NCT05718375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CU01-1001
Description: CU01-1001
Study NCT05718375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT05718375 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05008276 — intervention group
Intervention type: DRUG
Intervention: Aminohippurate Sodium Inj 20%
Description: Diagnostic aid/agent used to measure effective renal plasma flow (ERPF)
Study NCT05008276 — intervention group
Intervention type: DRUG
Intervention: Iohexol Inj 300 MG/ML
Description: Diagnostic aid/agent used to measure glomerular filtration rate (GFR)
Study NCT04899050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol (Epidiolex)
Description: Use of Epidiolex to control absence seizures.
Study NCT05008276 — intervention group
Intervention type: DRUG
Intervention: Dextran 40
Description: Diagnostic aid/agent used to measure glomerular size and selectivity
Study NCT04920357 — intervention group
Intervention type: DRUG
Intervention: Vaccination
Description: Persons that are vaccinated within the national and regional vaccine program are invited to participate in the follow-up study.
Study NCT06191627 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Patch testing
Description: Unlike many different dermatological diseases, a biopsy cannot easily distinguish ACD from irritant contact dermatitis or other forms of chronic dermatitis. Thus, the gold standard for diagnosis is patch testing. During patch testing, allergens are placed on the skin under occlusion using an aluminum disc and tape. When undergoing intensive testing for ACD, as many as 300 patches may be applied to a patient. Therefore, a large area of skin clear of rash is required, most often the back, but patches are frequently applied to the legs as well. Patches are applied by clinic patch technicians. They will proceed with their normal procedures, following the randomization to apply the patches to the appropriate location. Patches will be applied to the skin once, as is the normal standard of care. Patches are applied on day 1 and removed on day 3. Patients continue testing through day 5, though study elements will cease on day 3.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Occlusal Splint (OS).
Description: OS will be made of heat-cured acrylic by the same specialized dentist. These intraoral devices will be flate, rigid, will cover the entire dental arch, and will have the lowest possible height. The perimeter of the splint will have at least 11 dental contacts, light, symmetrical and pinpoint as possible. The patients will be instructed to use the splint every night during the study Two supervisions will be carried out 30 and 60 days after the use of the OS, in order to stabilize the contact points.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Occlusal Splint (OS).
Description: OS will be made of heat-cured acrylic by the same specialized dentist. These intraoral devices will be flate, rigid, will cover the entire dental arch, and will have the lowest possible height. The perimeter of the splint will have at least 11 dental contacts, light, symmetrical and pinpoint as possible. The patients will be instructed to use the splint every night during the study Two supervisions will be carried out 30 and 60 days after the use of the OS, in order to stabilize the contact points.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education (PNE).
Description: A power point presentation with metaphors and animated videos will be used. The PNE will be held in 10 sessions of 20 minutes each. The intervention will be developed using content according to the book Explain Pain and the web page www.retrainpain.org.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI).
Description: The participants will have to judge the laterality of different cervical images presented on the screen of a cell phone. The laterality task will be executed using an application called Recognize Neck, developed by the NOI group. The procedure will begin with a familiarization test with the Basic level followed by a laterality discrimination task. It will be performed using 20 images, with 5 seconds for each image, beginning with the Vanilla program and progressively increasing the difficulty using the Context and Abstract programs. The estimated time to complete the task will be about 10 minutes per session.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action Observation (AO).
Description: The patients will see videos showing the jaw and cervical exercises with the same series and repetitions that they will actively perform in the session. Therefore, the training of the action observation will be carried out dynamically. The patient will be asked to think and visualize the movement that he/she will have to perform later. It is estimated 10 minutes per session for the AO.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Jaw and Neck Exercises (JNE)
Description: A jaw and neck exercise program will be carried out in 3 series of 10 repetitions per session will be planned with 1minute rest between exercise. The exercises will be executed with a total time per session of 20 minutes, initially in the clinic and later at home. In the clinic, verbal and tactile instructions will be provided for the correct execution of the exercises and later they will be sent through WhatsApp and / or mail to perform them at home.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Jaw and Neck Exercises (JNE)
Description: A jaw and neck exercise program will be carried out in 3 series of 10 repetitions per session will be planned with 1minute rest between exercise. The exercises will be executed with a total time per session of 20 minutes, initially in the clinic and later at home. In the clinic, verbal and tactile instructions will be provided for the correct execution of the exercises and later they will be sent through WhatsApp and / or mail to perform them at home.
Study NCT05003349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Counselling.
Description: Counselling include education about the anatomical, biomechanical and psychosocial factors relationed with temporomandibular disorders, guidance regarding the parafunction jaw activities for eg will be taught the resting postural position of the mandible (teeth apart, lips slightly touching and tongue not pushing against the teeth).
Study NCT05600920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin (IL) 7-hyFc
Description: Structural Formula: NT-I7 is a fusion protein comprising human IL-7 fused to the human IgD hinge region. This in turn is fused to the N-terminal region of CH2 from IgD and two key regions of the antibody IgG4: C-terminal region of CH2 and the entire CH3 region. NT-I7 will be administered by IM injection once every 12 weeks for a total of 3 doses, with the final dose at week 24. In the absence of treatment delays due to AEs, a treatment course of 24 weeks will be pursued in all enrolled participants. The dose levels to be used in this study are 240, 480, and 720 microgram/kg. NT-I7 dosing will be determined using the weight recorded at the screening visit. The dose will be based on the participant s actual body weight, unless the participant has a BMI >=30 kg/m2, in which case adjusted body weight will be used.
Study NCT05092321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aquatic Occupational Therapy
Description: Group of 4-8 children, paired with a swim buddy. Intervention techniques including discrete teaching, motor shaping, behavioral management, therapeutic relationship and individualized goals.
Study NCT05321719 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comparison Condition
Description: In this Phase II project, BR2S will be evaluated for efficacy relative to a usual care control. Investigators expect BR2S to improve outcomes on behavioral change, self-efficacy, establishment of a dental home, knowledge, and attitudes in real settings relative to the usual care condition. The outcome measures include a direct clinical dental measure as well as observational measures of parental behavior. The study will also provide important information regarding the various types and combinations of BeReady2Smile product components for dissemination. The long-term goal of the program is to help parents provide the foundation for a lifetime free from preventable oral disease.
Study NCT05321719 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BeReady2Smile video only
Description: The video will be viewed at the Head Start site after informed consent and T1 questionnaires and plaque assessment. The video will include concrete demonstrations and feature diversity in settings and actors in video content derived from actual peer-based parenting education sessions. Parents' ability to see themselves in the content makes them more likely to engage in discussions about dental health. Supporting these conversations has been identified as an important need. For example, in a recent environmental scan prepared by the Association of State and Territorial Dental Directors the lack of communication strategies was identified as a gap in oral health educational resources. Specifically mentioned was the lack of oral health curricula that support interactive communication between families and home visitors. Families struggle with such dialogues.
Study NCT05321719 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BeReady2Smile video and BeReady2Smile app completely self-guided
Description: In addition to the BeReady2Smile video as described above, the BeReady2Smile app includes: (a) presentation of concepts, behaviors, and examples via video and text, (b) electronically presented check-in questions recorded to a database for review, (c) capture of a 5-minute video of parent-child interactions uploaded for later review by the parent, using a mobile application, (d) daily dental activities (homework), and (e) program feedback recorded to the database. BeReady2Smile will be designed such that before the parent can go on to a new area of learning, the parent must complete the previous lesson. Participants can go back and review previous material in a non-linear format. The database and log-files record all computer activities to track use of each intervention component.
Study NCT05321719 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complete BeReady2Smile video and BeReady2Smile app guided by a Coach
Description: In addition to the BeReady2Smile video and BeReady2Smile app described above, the complete intervention includes support via phone and text from a trained facilitator/coach who builds supportive one-on-one relationships with the parent and gives feedback on parent-recorded videos of parent-child interactions of tooth-brushing, designed to facilitate learning and promote engagement with their oral health professional; and tools to create a long-term follow-up plan. Dental behaviors will be tailored for children's developmental level (e.g. twice daily tooth brushing for preschoolers and limiting sugar sweetened beverages or milk in bottles at bed for infants).
Study NCT06506435 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Two Dimensional (2D) Informational Video
Description: A 30-minute informational video. The two dimensional (2D) video provides information about the radiotherapy process. Participants will receive this one-time intervention in-person, prior to treatment.
Study NCT06506435 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: First-Person Virtual Reality Video
Description: A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a first-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.
Study NCT06506435 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Third-Person Virtual Reality Video
Description: A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a third-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.
Study NCT06574815 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Early implant loading
Description: Patients underwent definitive restoration at 6 weeks after implant surgery (early loading).
Study NCT06574815 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early implant loading
Description: Patients underwent definitive restoration at 6 weeks after implant surgery (early loading).
Study NCT06574815 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Delayed implant loading
Description: Patients underwent definitive restoration at 6 months after implant surgery (delayed loading).
Study NCT06574815 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: GBR using an SIS membrane
Description: An small intestine submucosa (SIS) membrane was used in the guided bone regeneration (GBR) surgery.
Study NCT06574815 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: GBR using an Bio-Gide membrane
Description: An Bio-Gide membrane was used in the guided bone regeneration (GBR) surgery.
Study NCT06574815 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: GBR using an Bio-Gide membrane
Description: An Bio-Gide membrane was used in the guided bone regeneration (GBR) surgery.
Study NCT05711641 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine 10 MG/ML
Description: Application of 10% topical lidocaine in the external auditory canal of tinnitus patients.
Study NCT05711641 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Distilled water
Description: Application of distilled water in the external auditory canal of tinnitus patients.
Study NCT04576091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04576091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT and/or PET-CT scan
Study NCT04576091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elimusertib
Description: Given PO
Study NCT04576091 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT04576091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET-CT scan
Study NCT04576091 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04576091 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CKD What You Need To Know Workbook System
Description: 139 page Workbook including CKD Action Plan, Web-Based Resources, Interactive CKD Patient education material
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CKD Action Plan
Description: Goals based on international guidelines that can protect kidney function (1 knowledge and 10 action goals) Patient education material used separately for control arm.
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: CKD Action Plan
Description: Goals based on international guidelines that can protect kidney function (1 knowledge and 10 action goals) Patient education material used separately for control arm.
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CKD Web-based Resource List
Description: CKD Patient education material used separately for control arm
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: CKD Web-based Resource List
Description: CKD Patient education material used separately for control arm
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Food Label reading exercise
Description: CKD Patient education material used separately in all arms.
Study NCT05138419 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Food Label reading exercise
Description: CKD Patient education material used separately in all arms.
Study NCT06338982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Interoperative wisdom tooth removal in conjunction with BSSO
Description: The objective of the present randomized controlled trial is to assess the fracture pattern, condylar segment positioning, frequency of complications, and PROMs following BSSO with or without impacted mandibular third molars. this is illustrated by the fact that the test group had their wisdom teeth removed in connection with the sagittal split of the mandible (the BSSO surgery). Subsequently, all outcome measures are compared with the control group, who had their wisdom teeth removed 6 months prior their BSSO surgery.
Study NCT06579599 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: an integrated working group nursing
Description: (1) Establishment of an integrated team in the operating room; (2) Development of a nursing plan; (3) Nursing safety training and reflection in the operating room; (4) Designate a person to manage instruments and equipment in the operating room and establish protocols (5) Nurses should also participate in the development of the patient's individualized surgical plan communicate with the surgeon about the preparation of items needed for surgery to ensure seamless coordination. Assist anesthesiologists and surgeons and oversee the implementation of aseptic procedures.
Study NCT05850832 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esmolol
Description: loading dose 1 mg/kg followed by maintenance dose of 30 μg/kg/min throughout the surgery.
Study NCT05850832 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium sulfate
Description: loading dose 40 mg/kg over a period of 15 mins and maintenance 15 mg/kg/h throughout the surgery.
Study NCT04674241 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: Ten minutes after anesthesia induction and endotracheal intubation, patients assigned to dexmedetomidine group were given a loading dose of dexmedetomidine 0.6 μg/kg over 10 minutes, followed by continuous infusion at a rate of 0.4 μg/kg/h until the start of dural closure.
Study NCT04674241 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% saline
Description: 0.9% saline is administered with the same volume at the same speed as the other group.
Study NCT04715568 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Losartan
Description: 50 mg tablets taken orally
Study NCT05497037 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: Sham stimulation for 15 min
Study NCT03487627 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Electronic and Care Support Manager Contact
Description: This intervention will consist of electronic and Care Support Manager (CSM) contacts with parents from the first week following their adolescent's discharge from hospitalization through the first 3 months after discharge. The electronic application content will be accessible and delivered to parents weekly. Parents will also be able to enter a keyword on their electronic device to access content and material in real time. The CSM contacts will supplement the informational content delivered electronically by providing opportunities to ask questions about the electronic application material, and by checking on progress toward treatment follow through for their youth, identifying and problem solving any difficulties and concerns, and addressing health needs of each parent.